View More Recent Stories

Dec 11, 2024 07:19AM Ligand Pharma (LGND) PT Raised to $150 at Oppenheimer
Dec 10, 2024 09:15AM Ligand Pharma (LGND) Introduces 2025 Guidance
Dec 3, 2024 08:09AM Ligand Pharma (LGND) PT Raised to $141 at RBC Capital Ahead of Investor Day
Nov 7, 2024 07:17AM Ligand Pharma (LGND) Tops Q3 EPS by 50c ; Offers Guidance
Oct 21, 2024 06:54AM Ligand Pharma (LGND) PT Raised to $157 at H.C. Wainwright
Jul 30, 2024 03:16AM RBC Capital Starts Ligand Pharma (LGND) at Outperform
Jul 24, 2024 06:33AM Pieris Pharma (PIRS) and Palvella Therapeutics to Merge
Jul 24, 2024 06:30AM Palvella Therapeutics and Pieris Pharmaceuticals Announce Definitive Merger Agreement
Jul 9, 2024 08:50AM Ligand Pharma (LGND) PT Raised to $140 at Craig-Hallum
Jul 8, 2024 07:03AM Ligand Pharma (LGND) to Buy Apeiron Biologics for $100M Cash
Jun 28, 2024 06:40AM H.C. Wainwright Reiterates Buy Rating on Ligand Pharma (LGND)
Jun 27, 2024 08:03AM Ligand Pharma (LGND) Verona Pharma Announces FDA Approval of Ohtuvayre, First Inhaled Novel Mechanism for Maintenance Treatment of COPD in More Than 20 Years
View More Recent Stories